By Graham Wylie, CEO, Medical Research Network Ltd. The continuing rise of patient-centricity within the drug development industry is a crucial consideration for sponsors when designing their clinical development plans.

Read the entire article here: Home Clinical Trial Visits – A Patient Centric Solution